Edition:
United Kingdom

Cellectis SA (CLLS.OQ)

CLLS.OQ on NASDAQ Stock Exchange Global Market

14.96USD
7:59pm BST
Change (% chg)

$0.15 (+1.01%)
Prev Close
$14.81
Open
$14.67
Day's High
$14.96
Day's Low
$14.56
Volume
20,304
Avg. Vol
43,408
52-wk High
$30.90
52-wk Low
$13.84

About

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid... (more)

Overall

Beta: --
Market Cap(Mil.): $1,013.89
Shares Outstanding(Mil.): 35.42
Dividend: --
Yield (%): --

Financials

  CLLS.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.24 -- --
ROI: -27.62 8.90 13.82
ROE: -27.69 10.04 15.24

BRIEF-Cellectis Q4 Operating Loss Widens To 29.3 Million Dollars

* ANNOUNCED ON MONDAY, CELLECTIS REPORTS 4TH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS

12 Mar 2019

Earnings vs. Estimates